Intriguingly, recent research identified a protein (ovarian cancer immuno‐reactive antigen domain containing 1 [OCIAD1]), that can specifically control levels of TIMM17A‐containing TIM23 (unpublished data). Here, TIMM17A is linked to ovarian carcinoma.